Hier beginnt der Kopfbereich - Meta-Navigation und Logos

Link zur UKT HomepageLogo EBERHARD KARLS UNIVERSITÄT TÜBINGEN
 
Kein Link zur Sprachversion EN EN


Hier beginnt die Unternavigation für den Bereich


Ihr Ausdruck wurde in der folgenden Navigationsebene erstellt:


Hier beginnt der Inhaltsbereich
Willkommen im Forschungsportal
Visual Content 1
Visual Content 2

2007

Publikationen 2007


Bethke, TD, Böhmer G, Hermann R, Hauns B, Fux R, Mörike K, David M, Knörzer D, Wurst W, Gleiter CH: Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor. J Clin Pharmacol 47:26-36, 2007


Vagin S, Frickenschmidt A, Kammerer B, Hanack M: Reactivity of dehydrometallophthalocyanines and -porphyrazines. Chemistry 12:985-991, 2007


Anderle CH, Alt S, Gulder T, Bringmann G, Kammerer B, Gust B, Heide L: Biosynthesis of clorobiocin: investigation of the transfer and methylation of the pyrrolyl-2-carboxyl moiety.
Arch Microbiol 187:227-237, 2007


Kammerer B, Scheible H, Zurek G, Godejohann M, Zeller KP, Gleiter CH, Albrecht W, Laufer S: In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS. Xenobiotica 37:280-297, 2007


Kammerer B, Scheible H, Albrecht W. Gleiter CH, Laufer S: Pharmacokinetics of ML3403, a 4-pyridinylimidazole-type p 38 MAP kinase inhibitor. Drug Metab Dispos 35:875-883, 2007


Wolpert M, Gust B. Kammerer B, Heide L: Effects of deletions of mbtH-like genes on clorobiocin biosynthesis in Streptomyces coelicolor. Microbiol 153:1413-1423, 2007


Hauser Dr, Scior T, Domeyer DM, Kammerer B. Laufer S: Snythesis, Biological Testing, and Binding Mode Prediction of 6,9 Diarylpurin-8-ones as p38 MAP Kinase Inhibitor.
J Med Chem 50:2060-2066, 2007


Anderle, C, Li SM, Kammerer B, Gust B, Heide L: New aminocoumarin antibiotics derived from 4-hydroxycinnamic acid are formed after heterologous expression of a modified clorobiocin biosynthetic gene cluster. J Antibio 60:504-510, 2007


Anderle C, Hennig S, Kammerer B, Li SM, Wessjohann, Gust B, Heide L: Improved mutasynthetic approaches for the production of modified aminocoumarin antibiotics.
Chem Biol 24:955-967, 2007


Danielyan L, Tolstonog G, Traub P, Salvetter J, Gleiter CH, Reisig D, Gehardt R, Buniatian GH: Colocalization of glial fibrillary acidic protein, metallothionein, and MHC II in human, rat, NOD/SCID, and nude mouse skin keratinocytes and fibroblasts.
J Invest Dermatol 127:555-563, 2007


Danielyan L, Lourhmati A, Verleysdonk S, Kabisch D, Proksch B, Thiess U, Umbreen S. Schmidt B, Gleiter CH: Angiotensin Receptor Type1 Blockade in Astroglia Decreases Hypoxia-induced Cell Damage and TNF alpha Release. Neurochem Res 32:1489-98, 2007


Ufer M, Meyer S, Junge O, Selke G, Volz HP, Hedderich J, Gleiter CH: Patterns and prevalence of antidepressant drug use in the German state of Baden-Württemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 16:1153-1160, 2007


Grenz A, Zhang H, Weingart J, Wietersheim S, Eckle T, Schnermann J, Kochle C, Kloor D, Gleiter CH, Vallon V, Eltzschig K. Oßwald H: Lack of effect of extracellular adenosine generation and signalling on renal erythropoietin secretion during hypoxia.
Am J Physiol Renal Physiol 293:1501-1511, 2007


Dilger K, Fux R, Röck D, Mörike K, Gleiter CH:Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: a double drug interaction study.
J Clin Pharmcol 47:1532-1539, 2007


Mörike K, Gleiter CH: Digoxin: Kommt der alte (Finger-) Hut wieder zurück?
Arzneiverordnung in der Praxis 1:17-18, 2007


Mörike K: Kompendium evidenzbasierte Medizin.
Verlag Hans Huber, S. 565 ff, S. 573 ff, S. 577 ff,2007


Gleiter CH, Volz HP: Antidementiva.
Wissenschaftliche Verlagsgesellschaft Band 19:1-190, 2007


Müssig K, Knaus-Dittmann D, Schmidt H, Mörike K, Häring HU: Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment. Clin Endocrin 66:604-605, 2007


Fux R, Mörike K, Pröhmer AM, Delabar U, Schäffeler E, Gleiter CH, Schwab M: Psoriasis aggravation and metroprolol treatment - a prospective observational case study.
Int J Clin Pharmacol Ther 45:659-661, 2007


Böhmer GM, Gleiter CH, Nassr N, Hünnemeyer A, Walz A, Lahu G: Effect of the dual pathway inhibitor cimetidine on the pharmacokinetics of roflumilast and its active N-oxide.
Basic & Clin Pharmacol & Toxicol 101:S. 371, 2007


Dilger K, Fux R, Röck D, Mörike K, Gleiter CH: No effect of high-dose metronidazole on cytochrome P450 3 A activity in a drug interaction study with sensitive substrate budensonide.
Basic & Clin Pharmacol & Toxicol 101:S. 372, 2007


zurück zur Übersicht






Hier beginnt die Marginalspalte Suche und verschieden Module
Schnelleinstieg





Hier beginnt die Fusszeile - Impressum und Datenschutz